🇺🇸 FDA
Patent

US 10865226

Peptide showing melanogenesis promoting activity and use thereof

granted A61KA61K2800/10A61K38/00

Quick answer

US patent 10865226 (Peptide showing melanogenesis promoting activity and use thereof) held by CAREGEN CO., LTD. expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAREGEN CO., LTD.
Grant date
Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2800/10, A61K38/00, A61K8/64